Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laetitia Padovani

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|March 23, 2011
Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?Nicolas André, Laetitia Padovani, Eddy Pasquier
Drug News & Perspectives|April 7, 2010
Metronomic chemotherapy: Back to the future!Nicolas André, Laetitia Padovani, Arnauld Verschuur
Progress in Neurological Surgery|January 13, 2012
γ knife radiosurgery of brain metastasis from breast cancerLaetitia Padovani, Xavier Muracciole, Jean Régis
Nature Reviews. Clinical Oncology|July 14, 2011
Breast cancer--what about radiosurgery for brain metastasis?Laetitia Padovani, Jean Marie Regis, Xavier Muracciole
Current Opinion in Oncology|September 5, 2021
Current treatments of medulloblastomaKevin Beccaria, Laetitia Padovani, Yassine Bouchoucha, et al.
Nature Reviews. Neurology|September 12, 2012
Neurocognitive function after radiotherapy for paediatric brain tumoursLaetitia Padovani, Nicolas André, Louis S Constine, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
MedulloblastomaLaetitia Padovani, Nicolas André, Jean Claude Gentet, et al.
Journal of Pediatric Hematology/Oncology|October 9, 2012
Metronomic scheduling of anticancer agents for a refractory orbital pseudotumor in a childJamila Elhoudzi, Angélique Rome, Laetitia Padovani, et al.
Ecancermedicalscience|September 14, 2017
Necrotic ulcerated and bleeding striae distensae following bevacizumab in a palliative setting for gliobastomatosis cerebriOlivia Laugier, Laetitia Padovani, Arnauld Verschuur, et al.
Pediatric Blood & Cancer|March 6, 2010
Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?Emilie Moreau, Nicolas André, Carole Coze, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|March 23, 2011
Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?Nicolas André, Laetitia Padovani, Eddy Pasquier
Drug News & Perspectives|April 7, 2010
Metronomic chemotherapy: Back to the future!Nicolas André, Laetitia Padovani, Arnauld Verschuur
Progress in Neurological Surgery|January 13, 2012
γ knife radiosurgery of brain metastasis from breast cancerLaetitia Padovani, Xavier Muracciole, Jean Régis
Nature Reviews. Clinical Oncology|July 14, 2011
Breast cancer--what about radiosurgery for brain metastasis?Laetitia Padovani, Jean Marie Regis, Xavier Muracciole
Current Opinion in Oncology|September 5, 2021
Current treatments of medulloblastomaKevin Beccaria, Laetitia Padovani, Yassine Bouchoucha, et al.
Nature Reviews. Neurology|September 12, 2012
Neurocognitive function after radiotherapy for paediatric brain tumoursLaetitia Padovani, Nicolas André, Louis S Constine, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
MedulloblastomaLaetitia Padovani, Nicolas André, Jean Claude Gentet, et al.
Journal of Pediatric Hematology/Oncology|October 9, 2012
Metronomic scheduling of anticancer agents for a refractory orbital pseudotumor in a childJamila Elhoudzi, Angélique Rome, Laetitia Padovani, et al.
Ecancermedicalscience|September 14, 2017
Necrotic ulcerated and bleeding striae distensae following bevacizumab in a palliative setting for gliobastomatosis cerebriOlivia Laugier, Laetitia Padovani, Arnauld Verschuur, et al.
Pediatric Blood & Cancer|March 6, 2010
Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?Emilie Moreau, Nicolas André, Carole Coze, et al.
Pageof 9